Pharmaceuticals Market Research Reports

"...... 2023 and is anticipated to reach US$ 238 million by 2030, witnessing a CAGR of 8.0% during The forecast period 2024-2030. The market for recombinant human endostatin is important in cancer treatment. Trends include research into combinat......"

"...... of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increase from 1005 billion in 2018 ......"

"...... CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. ......"

"...... erleukins is primarily in The field of immunology and pharmaceutical research. Trends include The development of targeted therapies and immunomodulators based on interleukin research. This report aims to provide a comprehensive presentation of......"

"...... 0. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2......"

"...... S$ 9811.6 million by 2030, witnessing a CAGR of 6.0% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% d......"

"...... d to reach US$ 220.4 million by 2030, witnessing a CAGR of 7.6% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a C......"

"...... a CAGR of 8.5% during The forecast period 2024-2030. North American market for Dialysate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pa......"

"...... lion by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dalteparin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 20......"

"...... and is anticipated to reach US$ 220 million by 2030, witnessing a CAGR of 1.1% during The forecast period 2024-2030. Natriuretic peptides have clinical applications in diagnosing and managing heart failure and other cardiovascular conditions......"